On 16 September 2026, Touyun Biotech Group Limited released a notification to non-registered shareholders confirming that the English and Chinese versions of its 2026 Interim Report are now available on the company website (www.touyunbiotech.com.hk) and on HKEXnews (www.hkexnews.hk).

The company recommends shareholders access the report online. Those experiencing difficulties with email alerts or website access may obtain a complimentary printed copy by completing the enclosed Request Form and forwarding it to the Hong Kong branch share registrar, Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, or by emailing 1332-ecom@vistra.com. A prepaid mailing label is provided for local postage-free returns.

Shareholders wishing to receive future corporate communications electronically should supply a functional email address to their respective intermediaries—banks, brokers, custodians, nominees or HKSCC Nominees Limited. Until an email address is recorded, only hard-copy notices of publication can be sent.

Enquiries regarding these arrangements can be directed to Tricor Investor Services Limited on (+852) 2980 1333 between 09:00 and 18:00, Monday to Friday, excluding public holidays.